Editorial: MicroRNAs-clinical biomarkers for atrial fibrillation

Front Cardiovasc Med. 2023 Sep 6:10:1270461. doi: 10.3389/fcvm.2023.1270461. eCollection 2023.

Isabel Moscoso^{1

2}, Tania Martins-Marques^{3

4

5}, Diego Franco⁶

¹ Cardiology Group, Centre for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela and Department of Cardiology and Coronary Unit and Cellular and Molecular Cardiology Research Unit, Institute of Biomedical Research (IDIS-SERGAS), University Clinical Hospital, Santiago de Compostela, Spain.
² Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
³ Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, Univ Coimbra, Coimbra, Portugal.
⁴ Center for Innovative Biomedicine and Biotechnology (CIBB), Univ Coimbra, Coimbra, Portugal.
⁵ Clinical Academic Centre of Coimbra (CACC), Coimbra, Portugal.
⁶ Cardiovascular Development Group, Department of Experimental Biology, University of Jaén, Jaén, Spain.

No abstract available

Keywords: MACE; atrial fibrillation; biomarkers; circRNA; meta-analysis; microRNAs; non-coding RNAs.

Publication types